Enliven Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 1.2M | 20.47 |
| 2025-06-30 | $30M | 1.5M | 20.06 |
| 2025-03-31 | $22M | 1.1M | 19.68 |
| 2024-12-31 | $39M | 1.7M | 22.50 |
| 2024-09-30 | $44M | 1.7M | 25.54 |
| 2024-06-30 | $54M | 2.3M | 23.37 |
| 2024-03-31 | $41M | 2.4M | 17.59 |
| 2023-12-31 | $33M | 2.4M | 13.84 |
| 2023-09-30 | $32M | 2.4M | 13.66 |
| 2023-06-30 | $47M | 2.3M | 20.41 |
| 2023-03-31 | $50M | 2.3M | 21.90 |